Shardul Amarchand Mangaldas & Co. advises LeapFrog Investments in the Series C round of investment in Healthifyme Private Limited
August 9, 2021
Shardul Amarchand Mangaldas & Co. advised LeapFrog Investments (“LeapFrog”) in $75 million Series C round of investment in Healthifyme Private Limited (‘HealthifyMe’), which was led by LeapFrog and Khosla Ventures. Other investors participating in this round included Chirate Ventures, Unilever Swiss Holdings AG, Inventus Capital Partners Sistema Asia Fund and HealthQuad.
The transaction team was led by Anuj Bhasme, Partner; Avichal Mathur, Principal Associate; Hardik Thakker, Senior Associate; Apeksha Narula, Associate; and Shreeya Shukla, Associate. Employment Law team was led by Pooja Ramchandani, Partner; and Suryansh Gupta, Associate. Data Privacy team was led by Kirti Mahapatra, Partner; Veda Handa, Associate; and Shaileja Verma, Associate. Intellectual Property was led by Mukul Baveja, Partner.
Gunderson Dettmer Singapore, LLP and MD&T Partners advised HealthifyMe Private Limited and Tushar Vashisht on International and Indian aspects, respectively. Simmons & Simmons advised LeapFrog on Singapore aspects.
The Bar Council of India does not permit solicitation of work and advertising by legal practitioners and advocates. By accessing the Shardul Amarchand Mangaldas & Co. website (our website), the user acknowledges that:
The user wishes to gain more information about us for his/her information and use. He/She also acknowledges that there has been no attempt by us to advertise or solicit work.
Any information obtained or downloaded by the user from our website does not lead to the creation of the client – attorney relationship between the Firm and the user.
None of the information contained in our website amounts to any form of legal opinion or legal advice.
All information contained in our website is the intellectual property of the Firm.